Suicidality and Chronic Pain: Research/Risk Factors and Monitoring/Evaluation/Treatment in the Context of Opioid Tapering (211)

5–6 pm Friday, April 27

View a recording of this live session when you purchase 2018 Annual Meeting On Demand.

Chronic pain patients (CPPs) are at high risk for suicidality, which could be increased in the context of opioid tapering. This session presents recent research in this area along with monitoring techniques for suicidality development in CPPs undergoing opioid tapering. In addition, evaluation/treatment procedures for such CPPs will be discussed.

Suicidality and Chronic Pain: Research Status, Risk Factors, and Opioid Tapering Impact

David A. Fishbain, MD

Suicidality Monitoring/Evaluation/Treatment in the Chronic Pain Setting in the Context of Opioid Tapering

W. Michael Hooten, MD

Learning Objectives:

  • Recognize the high risk for suicidality of the CPP, which may be heightened in the context of opioid tapering.
  • Examine monitoring /evaluation /treatment procedures for CPPs undergoing opioid tapering.